Data on the spread and control of chlamydia, gonorrhoea, syphilis and other sexually transmitted infections in the community.

Sexually transmitted infections epidemiology: latest news

Sexually transmitted infections epidemiology news from aidsmap

More news

Sexually transmitted infections epidemiology news selected from other sources

  • People urged to practise safer sex after rise in STIs in England

    New data from Public Health England show there were around 448,000 cases of sexually transmitted infections diagnosed in 2018, an increase of 5% from 2017.

    04 June 2019 | Public Health England
  • Sexually transmitted infections and screening for chlamydia in England, 2018

    In 2018, there were 447,694 diagnoses of sexually transmitted infections made in England, a 5% increase since 2017, including a 26% increase in gonorrhoea diagnoses.

    04 June 2019 | Public Health England
  • Silver Singles: Why Are Sexually Transmitted Infections On The Rise In The Over 50s?

    Divorce, dating apps, and living longer means STIs are affecting more older people than ever before.

    03 June 2019 | Huffington Post
  • England: Sexual health figures mask serious trends and inequalities

    Sexual health must be sufficiently funded on a national level, to deliver high quality sexual health services and information, say the Health and Social Care Committee in its report on sexual health.

    02 June 2019 | Parliament
  • Women Have High Syphilis Rates, Too

    For women in the general population, the incidence of syphilis is at a 20-year high. But for women with HIV — particularly those who inject drugs — the incidence is 330% higher than that, data from a long-term study show. The biggest indicators of syphilis in women are hepatitis C infection and injection drug use. This means that providers should tailor syphilis screening to women with indicators of injection drug use, particularly in regions of the country hardest hit by injection drug epidemics.

    11 March 2019 | Medscape (requires free registration)
  • Gonorrhoea: drug resistance compromises recommended treatment in Europe

    In 2017, 27 EU/EEA countries collected and tested 3 248 gonococcal isolates which revealed that cefixime and azithromycin resistance (1.9% and 7.5% respectively) remained unchanged compared to 2016 (2.1% and 7.5%). However, the number of countries reporting resistant isolates for each antimicrobial increased. For the second year in a row, no isolates with resistance to ceftriaxone were detected in contrast to one in 2015, five in 2014 and seven in 2013.

    28 February 2019 | ECDC
  • US: STIs Drive 1 in 10 HIV Transmissions in Gay & Bi Men

    Chlamydia and gonorrhea make untreated HIV more transmittable and make HIV-negative people more susceptible to contracting the virus.

    04 February 2019 | Poz
  • 26% of black MSM in PrEP trial diagnosed with STI during follow-up

    More than 26% of black men who have sex with men, or MSM, who were enrolled in a pre-exposure prophylaxis, or PrEP, trial were diagnosed with an STI in follow-up, and younger study participants had higher rates of STIs than older participants, according to research published in Clinical Infectious Diseases.

    14 January 2019 | Healio
  • Stop blaming PrEP for the rise in STIs – the picture is more complex than that

    When MSM seek out PrEP, it is a decision that should be supported. To castigate them is to increase stigma and discourage their engagement with health services. We must encourage PrEP use, accept that condom use may fall as a result, design supportive care and be happy knowing that every averted HIV infection is a life-altering moment.

    10 December 2018 | The Conversation
  • The unexpected effects of the HIV prevention pill

    PrEP is great at blocking HIV, but as its use grows, so do fears that people will be more sexually reckless and spread other STIs. But researchers are coming to think that the opposite could be true.

    29 November 2018 | Mosaic
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.